May 9, 2023 10:58 AM EDTUpdated 11:23 AM

MarketingRx roundup: AbbVie debuts Vraylar campaign for depression; Amylyx re-ups “Get Inked” for ALS effort

Beth Snyder Bulik

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

Volastra unveils first human data of its solid tumor drug target

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?